Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on their ...

An open market share buyback program has also been initiated, signaling a robust vote of confidence in CBDL's growth strategy and financial stability. This strategic decision to repurchase outstanding ...

SCOTTSDALE, ARIZONA / ACCESS Newswire / December 2, 2025 / CBD Life Sciences Inc. (OTCID:CBDL) is gaining powerful investor momentum this week following a spotlight interview with CEO Lisa Nelson on ...

The U.S. marijuana dispensary market is projected to generate over $31.8 billion annually by 2025, creating multi-million-dollar opportunities for CBDL through dispensary partnerships and large-scale ...

With a staggering 1405.46% revenue surge since February 2024, CBDL continues its explosive expansion as Smoking Scholars places another major order in New York's $7.2 billion cannabis market.

With New York dispensaries projected to surpass $4.4 billion in annual sales by 2027, CBDL secures a transformative partnership poised to generate multi-million-dollar revenues and accelerate ...

Short interest for CBD Life Sciences gives investors a sense of the degree to which investors are betting on the decline of CBD Life Sciences's stock. Short interest data is updated every two weeks.

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...